Skip to main content
Signal8

Doherty James J.

SEC insider (Form 3/4/5 filer). CIK 0002009718. President and CDO at Acumen Pharmaceuticals, Inc. (ABOS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 16, 2026. Located in NEWTON, MA.

Companies Doherty James J. has filed insider reports for

  • Acumen Pharmaceuticals, Inc. (ABOS): Officer, President and CDO
Doherty James J. profile photo

Doherty James J.

CIK: 0002009718

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Acumen Pharmaceuticals, Inc. logo
ABOS

Acumen Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 16, 2026
    Award
    Direct
    166.9K shares-
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 8, 2026
    Sale
    Direct
    6.5K shares at avg. $1.82$12K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 7, 2026
    Sale
    Direct
    1.7K shares at avg. $1.99$3K
  • Acumen Pharmaceuticals, Inc. logo
    ABOS

    Acumen Pharmaceuticals, Inc.

    Jan 6, 2025
    Award
    Direct
    62.6K shares-

1-4 of 4